Systems, methods, and devices are described herein for evaluation, adjustment, and delivery of adaptive cardiac therapy. The systems, methods, and devices may utilize electrical heterogeneity information to determine and/or select one or more pacing settings and pacing type or configurations for a plurality of different heart rates. The adaptive cardiac therapy may deliver cardiac therapy at selected pacing settings such as, for example, A-V and/or V-V intervals, according to a presently measured heart rate and switch between left ventricular-only or biventricular cardiac pacing therapy also according to the presently measured heart rate.

In some examples, a method including detecting, via processing circuitry, an induced voltage in at least one of an electrode or a lead conductor of an implantable medical device, wherein the induced voltage is induced in the at least one of the electrode or the lead conductor of the implantable medical device by a radio frequency (RF) field generated by a magnetic resonance imaging (MRI) scanner; and modifying, via the processing circuitry, an MRI scan based on the detected induced voltage.

Disclosed herein is an implantable pulse generator for administering electrotherapy via an implantable lead. The pulse generator includes a housing and a header connector assembly coupled to the housing. The header connector assembly includes a connector assembly and a header enclosing the connector assembly. The connector assembly includes a support and a connector receptacle. The support extends at least partially about the connector receptacle and is at least partially responsible for having prevented injection molding material from entering the connector receptacle when the injection molding material was injection molded about the connector assembly in forming the header.

Disclosed herein is an implantable pulse generator for administering electrotherapy via an implantable lead. The pulse generator includes a housing and a header connector assembly coupled to the housing. The header connector assembly includes a connector assembly and a header enclosing the connector assembly. The connector assembly includes a support and a connector receptacle. The support extends at least partially about the connector receptacle and is at least partially responsible for having prevented injection molding material from entering the connector receptacle when the injection molding material was injection molded about the connector assembly in forming the header.

A hermetically sealed feedthrough assembly for an active implantable medical device having an oxide-resistant electrical attachment for connection to an EMI filter, an EMI filter circuit board, an AIMD circuit board, or AIMD electronics. The oxide-resistant electrical attachment, including an oxide-resistant sputter layer 165 is disposed on the device side surface of the hermetic seal ferrule over which an ECA stripe is provided. The ECA stripe may comprise one of a thermal-setting electrically conductive adhesive, an electrically conductive polymer, an electrically conductive epoxy, an electrically conductive silicone, an electrically conductive polyimide, or a thermal-setting electrically conductive polyimide, such as those manufactured by Ablestick Corporation. The oxide-free electrical attachment between the ECA stripe and the filter or AIMD circuits may comprise one of gold, platinum, palladium, silver, iridium, rhenium, rhodium, tantalum, tungsten, niobium, zirconium, vanadium, and combinations or alloys thereof.

A hermetically sealed feedthrough assembly for an active implantable medical device having an oxide-resistant electrical attachment for connection to an EMI filter, an EMI filter circuit board, an AIMD circuit board, or AIMD electronics. The oxide-resistant electrical attachment, including an oxide-resistant sputter layer 165 is disposed on the device side surface of the hermetic seal ferrule over which an ECA stripe is provided. The ECA stripe may comprise one of a thermal-setting electrically conductive adhesive, an electrically conductive polymer, an electrically conductive epoxy, an electrically conductive silicone, an electrically conductive polyimide, or a thermal-setting electrically conductive polyimide, such as those manufactured by Ablestick Corporation. The oxide-free electrical attachment between the ECA stripe and the filter or AIMD circuits may comprise one of gold, platinum, palladium, silver, iridium, rhenium, rhodium, tantalum, tungsten, niobium, zirconium, vanadium, and combinations or alloys thereof.

A patient monitoring system within an Electroconvulsive Therapy (ECT) device includes a patient monitoring channel including a first electrode and a second electrode, with each electrode coupled to a respective lead. The monitoring system also includes an Alternating Current source structured to inject a test current to the first electrode lead or the second electrode lead and a differential amplifier structured to measure differences between signals received from the first electrode lead and the second electrode lead. Related methods include evaluating a quality of an electrode contact with a skin surface by injecting a lead of the electrode and one input of a differential amplifier with a known electrical current, comparing a difference between an electrical signal received from the lead of the injected electrode as well as from a lead of a passive signal electrode, and evaluating the compared difference.

A patient monitoring system within an Electroconvulsive Therapy (ECT) device includes a patient monitoring channel including a first electrode and a second electrode, with each electrode coupled to a respective lead. The monitoring system also includes an Alternating Current source structured to inject a test current to the first electrode lead or the second electrode lead and a differential amplifier structured to measure differences between signals received from the first electrode lead and the second electrode lead. Related methods include evaluating a quality of an electrode contact with a skin surface by injecting a lead of the electrode and one input of a differential amplifier with a known electrical current, comparing a difference between an electrical signal received from the lead of the injected electrode as well as from a lead of a passive signal electrode, and evaluating the compared difference.

Implantable medical systems that include an implantable medical lead coupled to an implantable medical device for purposes of electrical stimulation therapy and/or sensing of physiological signals includes at least one twisted pair of conductors within the implantable medical lead. The twisted pair corresponds to a stimulation or sensing channel of the implantable medical device. The twisted pair provides attenuation of electromagnetic interference noise that is present at the lead or lead extension. The twisted pair may be present in a lumen of the implantable medical lead or encapsulated by the lead body. The twisted pair, along with any other conductors of the lead, may be of a linear configuration or may be coiled.

A shield layer is added to an existing lead or lead extension by applying the shield layer to the lead body between the proximal contact and distal electrode of the lead body. The shield layer may be covered with an outer insulative layer. An inner insulative layer may be applied over the lead body prior to adding the shield layer and the outer insulative layer. The shield layer may have a terminator applied to the end of the shield layer to prevent migration of the shield layer through the outer insulative layer. The shield layer may be of various forms including a tubular braided wire structure or a tubular foil. The tubular braided wire structure may be applied to the lead body by utilizing the lead body as a mandrel within a braiding machine.